Synthesis of Hybrid Cyclopeptides through Enzymatic Macrocyclization

Emilia Oueis; Brunello Nardone; Marcel Jaspars; Nicholas J. Westwood; James H. Naismith

doi:10.1002/open.201600134

Synthesis of Hybrid Cyclopeptides through Enzymatic Macrocyclization

Emilia Oueis, Brunello Nardone, Marcel Jaspars, Nicholas J. Westwood^*, James H. Naismith

^*Corresponding author for this work

Chemistry

Research output: Contribution to journal › Comment/debate › peer-review

21 Citations (Scopus)

8 Downloads (Pure)

Abstract

Natural products comprise a diverse array of molecules, many of which are biologically active. Most natural products are derived from combinations of polyketides, peptides, sugars, and fatty-acid building blocks. Peptidic macrocycles have attracted attention as potential therapeutics possessing cell permeability, stability, and easy-to-control variability. Here, we show that enzymes from the patellamide biosynthetic pathway can be harnessed to make macrocycles that are hybrids of amino acids and a variety of manmade chemical building blocks, including aryl rings, polyethers, and alkyl chains. We have made macrocycles with only three amino acids, one of which can be converted to a thiazoline or a thiazole ring. We report the synthesis of 18 peptide hybrid macrocycles, nine of which have been isolated and fully characterized.

Original language	English
Pages (from-to)	11-14
Number of pages	4
Journal	ChemistryOpen
Volume	6
Issue number	1
Early online date	13 Dec 2016
DOIs	https://doi.org/10.1002/open.201600134
Publication status	Published - 1 Feb 2017

Keywords

biotransformation
cyanobactin
hybrid macrocycles
macrocyclization
peptides

Access to Document

10.1002/open.201600134Licence: CC BY

Synthesis of Hybrid Cyclopeptides through EnzymaticMacrocyclization
© 2016 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/
Final published version, 875 KBLicence: CC BY

Cite this

@article{39295187997246d0998a1c2b2c5529fd,

title = "Synthesis of Hybrid Cyclopeptides through Enzymatic Macrocyclization",

abstract = "Natural products comprise a diverse array of molecules, many of which are biologically active. Most natural products are derived from combinations of polyketides, peptides, sugars, and fatty-acid building blocks. Peptidic macrocycles have attracted attention as potential therapeutics possessing cell permeability, stability, and easy-to-control variability. Here, we show that enzymes from the patellamide biosynthetic pathway can be harnessed to make macrocycles that are hybrids of amino acids and a variety of manmade chemical building blocks, including aryl rings, polyethers, and alkyl chains. We have made macrocycles with only three amino acids, one of which can be converted to a thiazoline or a thiazole ring. We report the synthesis of 18 peptide hybrid macrocycles, nine of which have been isolated and fully characterized.",

keywords = "biotransformation, cyanobactin, hybrid macrocycles, macrocyclization, peptides",

author = "Emilia Oueis and Brunello Nardone and Marcel Jaspars and Westwood, {Nicholas J.} and Naismith, {James H.}",

note = "Acknowledgements We thank Dr. G. Mann and Dr. A. Bent for supplying the enzymes and the useful discussions, and Dr. T. Lebl for the useful NMR discussions. This work was supported by the European Research Council (339367), UK Biotechnology and Biological Sciences Research Council (K015508/1), the Wellcome Trust [TripleTOF 5600 mass spectrometer (094476), the MALDI TOF-TOF Analyzer (079272AIA), 700 NMR], and the EPSRC UK National Mass Spectrometry Facility at Swansea University. J.H.N., M.A.J., and N.J.W. are named on patents that have been filed by St. Andrews and Aberdeen Universities to commercialize the enzymes (PatG) and (LynD) used in the study. No income derives from the patent.",

year = "2017",

month = feb,

day = "1",

doi = "10.1002/open.201600134",

language = "English",

volume = "6",

pages = "11--14",

journal = "ChemistryOpen",

issn = "2191-1363",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Synthesis of Hybrid Cyclopeptides through Enzymatic Macrocyclization

AU - Oueis, Emilia

AU - Nardone, Brunello

AU - Jaspars, Marcel

AU - Westwood, Nicholas J.

AU - Naismith, James H.

N1 - Acknowledgements We thank Dr. G. Mann and Dr. A. Bent for supplying the enzymes and the useful discussions, and Dr. T. Lebl for the useful NMR discussions. This work was supported by the European Research Council (339367), UK Biotechnology and Biological Sciences Research Council (K015508/1), the Wellcome Trust [TripleTOF 5600 mass spectrometer (094476), the MALDI TOF-TOF Analyzer (079272AIA), 700 NMR], and the EPSRC UK National Mass Spectrometry Facility at Swansea University. J.H.N., M.A.J., and N.J.W. are named on patents that have been filed by St. Andrews and Aberdeen Universities to commercialize the enzymes (PatG) and (LynD) used in the study. No income derives from the patent.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Natural products comprise a diverse array of molecules, many of which are biologically active. Most natural products are derived from combinations of polyketides, peptides, sugars, and fatty-acid building blocks. Peptidic macrocycles have attracted attention as potential therapeutics possessing cell permeability, stability, and easy-to-control variability. Here, we show that enzymes from the patellamide biosynthetic pathway can be harnessed to make macrocycles that are hybrids of amino acids and a variety of manmade chemical building blocks, including aryl rings, polyethers, and alkyl chains. We have made macrocycles with only three amino acids, one of which can be converted to a thiazoline or a thiazole ring. We report the synthesis of 18 peptide hybrid macrocycles, nine of which have been isolated and fully characterized.

AB - Natural products comprise a diverse array of molecules, many of which are biologically active. Most natural products are derived from combinations of polyketides, peptides, sugars, and fatty-acid building blocks. Peptidic macrocycles have attracted attention as potential therapeutics possessing cell permeability, stability, and easy-to-control variability. Here, we show that enzymes from the patellamide biosynthetic pathway can be harnessed to make macrocycles that are hybrids of amino acids and a variety of manmade chemical building blocks, including aryl rings, polyethers, and alkyl chains. We have made macrocycles with only three amino acids, one of which can be converted to a thiazoline or a thiazole ring. We report the synthesis of 18 peptide hybrid macrocycles, nine of which have been isolated and fully characterized.

KW - biotransformation

KW - cyanobactin

KW - hybrid macrocycles

KW - macrocyclization

KW - peptides

UR - http://www.scopus.com/inward/record.url?scp=85006713711&partnerID=8YFLogxK

U2 - 10.1002/open.201600134

DO - 10.1002/open.201600134

M3 - Comment/debate

AN - SCOPUS:85006713711

VL - 6

SP - 11

EP - 14

JO - ChemistryOpen

JF - ChemistryOpen

SN - 2191-1363

IS - 1

ER -

Synthesis of Hybrid Cyclopeptides through Enzymatic Macrocyclization

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this